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Background: In recent years, several methods have been developed for repairing full-thickness cartilage defects
by tissue engineering using mesenchymal stem cells. Most of these use scaffolds to achieve sufficient thickness.
However, considering the potential influence of scaffolds on the surrounding microenvironment, as well as
immunological issues, it is desirable to develop a scaffold-free technique. In this study, we developed a novel
technique, a scaffold-free autologous construct derived from bone marrow-derived mesenchymal stem cells
(BM-MSCs), and successfully use this technique to regenerate cartilage and subchondral bone to repair an
osteochondral defect in rabbit knees.
Methods: BM-MSCs were isolated from bone marrow liquid aspirated from the iliac crest of rabbits. After expansion
in culture dishes and re-suspension in 96-well plates, the cells spontaneously aggregated into a spheroid-like
structure. The spheroids were loaded into a tube-shaped Teflon mold with a 5-mm height and maintained under
air-liquid interface conditions. These loaded spheroids fused with each other, resulting in a cylinder-shaped
construct made of fused cells that conformed to the inner shape of the mold. The construct was implanted into
an osteochondral defect in rabbit knees and histologically analyzed 24 and 52 weeks after implantation using
Wakitani’s scoring system.
Results: Both bone and cartilage were regenerated, maintaining a constant thickness of cartilage. The mean
histological score was 10 ± 1.7 in the 24-week group and 9.7 ± 0.6 in the 52-week group. There was no significant
difference between the 24- and 52-week groups in either parameter of the score, indicating that no deterioration
of the repaired tissue occurred during the intervening period.
Conclusions: Using our novel technique, which employs a three-dimensional scaffold-free autologous construct
derived from BM-MSCs, we successfully achieved simultaneous regeneration of bone and cartilage for up to 1 year
in vivo. This method has potential for clinical use as a safe and effective method for repairing bone and cartilage defects.
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Repairing damaged cartilage, as in traumatic lesions of
the joint surface or degenerative damage due to osteo-
arthritis, remains a clinical challenge because of the poor
self-healing ability of cartilage [1]. Several existing treat-
ments for the repair of damaged cartilage, including
mosaicplasty [2], microfracture [3], and autologous chon-
drocyte implantation (ACI) [4], have been used successfully
in patients to relieve pain and improve joint function.
However, the long-term results of mosaicplasty and micro-
fracture are unsatisfactory because the replaced tissue is
not physiological hyaline cartilage, but mostly fibrous
cartilage, which lacks suitable mechanical properties
[5,6]. Furthermore, in histological evaluations of the
repaired tissue, ACI exhibited no significant difference
compared to microfracture in a randomized trial [7], and
the repaired tissue was predominantly fibrous cartilage.
Tissue engineering of functional articular cartilage
could help address these issues. In recent years, several
methods have been developed to repair full-thickness
cartilage defects. Some of these methods use synthetic
or biological scaffolds to achieve sufficient thickness,
mechanical function, support cell attachment, migration,
proliferation, and differentiation [8,9]. However, these ma-
terials can influence the surrounding microenvironments
[10] or cause immunological problems [11,12].
Several scaffold-free systems have also been investi-
gated [13-16]. Without using a scaffold, however, it is
difficult to create enough thickness to fill in the defect.
A thickness of 5 mm is necessary to fill a full-thickness
articular cartilage defect in the knee. Furthermore, with
or without using a scaffold, it is even more challenging for
the current methods to regenerate both articular cartilage
and subchondral bone in the context of an osteochondral
defect, which sometimes occurs in trauma, osteochondri-
tis dissecans, osteonecrosis, or osteoarthritis.
Adherent cells grown in suspension form spheroids
(aggregates) in order to avoid cell death. We confirmed
this phenomenon using bone marrow-derived mesenchy-
mal stem cells (BM-MSCs). Furthermore, we developed a
novel method for fusing spheroids derived from BM-
MSCs to make a large construct without using a scaffold.
Loading the spheroids into a molding chamber can pro-
duce a columnar structure consisting of fused spheroids;
we named this structure “high-density mesenchymal stem
cell, scaffold-free autologous construct” (HDMAC). We
hypothesized that HDMACs could be used to regenerate
both articular cartilage and subchondral bone in the con-
text of an osteochondral defect. Furthermore, because
many other reports have achieved successful short-term
cartilage repair, we focused on achieving a relatively long-
term result (up to 1 year) in an animal model.
The purposes of this study were to demonstrate our
method for making spheroids and a scaffold-free construct(HDMAC) using only undifferentiated BM-MSCs and to
evaluate the 1-year outcome of simultaneous regeneration
of cartilage and subchondral bone in an osteochondral
defect in rabbit knees.
Materials and methods
Rabbits
All experiments followed protocols approved by the insti-
tutional animal care and use committee (approval number:
A21-204-2). Fifteen mature female Japanese white rabbits
(Japan Kyudo Inc, Tosu, Japan) with a mean weight of
3.9 kg (range 3.5–4.2) were eventually used for this study
after several pilot studies to establish the procedures in
detail. Animals were housed in separate cages at the ani-
mal center of our institution with free access to water and
standard food. Two or three rabbits were euthanized at 3,
6, and 12 weeks and three rabbits were euthanized at each
of two time points (24 and 52 weeks) after implantation
for histological analysis.
Culture medium
Dulbecco’s modified Eagle’s medium (DMEM) (Nissui
#05915, Nissui Pharmaceutical, Tokyo, Japan) containing
10% fetal bovine serum (FBS) (HyClone, Logan, UT, USA),
100 U/mL penicillin, and 100 μg/mL streptomycin (Sigma-
Aldrich, St. Louis, MO, USA) was used. No differen-
tiation agents were used from cell isolation to construct
formation.
Isolation and culture of mesenchymal stem cells (MSCs)
MSCs were isolated as described previously with some
modifications in the method [9]. Briefly, bone marrow
liquid was aspirated from the iliac crest of the rabbits
under general anesthesia, and the obtained bone marrow
was mixed with heparin. After centrifugation at 1,000 rpm
for 5 min, the buffy coat of the bone marrow liquid was
aspirated and expanded into a 15-cm culture dish con-
taining DMEM and 10% FBS. The cells obtained were
expanded until they reached the necessary numbers
(~4 × 107 cells).
Spheroid formation
Cells were detached by recombinant trypsin replacement,
re-suspended in DMEM plus 10% FBS, and then divided
into 96-well plates designed to prevent cells from adhering
to the culture surface (Sumilon PrimeSurface, Sumitomo
Bakelite, Tokyo, Japan) at 4 × 104 cells per well. After incu-
bation at 37°C and 5% CO2 for 2 days, the cells spontan-
eously aggregated into a spheroid-like structure (Figure 1a).
Construct formation
The spheroids described above were loaded into a
handmade tube-shaped Teflon mold with a diameter of
4.6 mm and a height of 5 mm (Figure 1b). At the bottom
Figure 1 Manufacturing HDMACs. (a) BM-MSCs were isolated from bone marrow liquid aspirated from rabbits. After expansion, re-suspension,
and incubation, the cells spontaneously aggregated into a spheroid-like structure. Each scale unit represents 1 μm. (b) A handmade tube-shaped
Teflon mold with a diameter of 4.6 mm and a height of 5 mm. The spheroids described in (a) were loaded into this mold. Each scale unit
represents 1 mm. (c) The tube-shaped mold was maintained under air-liquid interface conditions and incubated for a week. These loaded spheroids
fused with each other, and a cylinder-shaped construct made with fused cells was obtained according to the inner shape of the mold. Each scale unit
represents 1 mm. (d) Safranin O staining of HDMACs after 1 week of incubation. Scale bar =100 μm. (N = 1).
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base disc was used for handling of the construct. Six
hundred to seven hundred spheroids were needed to make
one construct. The tube-shaped mold was maintained
under air-liquid interface conditions and incubated at
37°C and 5% CO2 for 1 week in DMEM plus 10% FBS.
These loaded spheroids fused with each other, resulting
in formation of a cylinder-shaped construct made of fused
cells that conformed to the inner shape of the mold
(Figure 1c). We named these structures “high-density
mesenchymal stem cell, scaffold-free autologous con-
structs” (HDMACs).
Scanning electron microscopy (SEM)
Constructs were fixed with 1% glutaraldehyde/1.44% para-
formaldehyde in buffer at 37°C for 60 min, frozen in liquid
nitrogen, and lyophilized. Next, samples were sputter-
coated with an alloy of platinum and palladium and then
observed by scanning electron microscopy (JSM 840A,
JEOL USA, Peabody, MA, USA).
Implantation in vivo
After general anesthesia, a cylindrical defect was cre-
ated in the articular cartilage of the patella groove. Thediameter of the defect was set to 4.8 mm. The depth was
determined to be the same as the height of the cell
construct, usually 4–5 mm in depth, which reached
the middle layer of the subchondral bone. The con-
struct was gently implanted into the defect, the Tef-
lon disc was removed, and the top of the construct
was flattened using the surgeon’s finger. No patches
were placed on the implant surface. The osteochon-
dral defect in the contralateral knee was left empty
for controls. After washing and closure of the wound,
the knee was immobilized with a cast for 1 week. In
a pilot study, individual rabbits were euthanized at 3,
6, and 12 weeks to confirm the early regeneration
process by histological evaluation. After obtaining positive
results from this pilot study, three knees were obtained at
each of two time points (24 and 52 weeks) and subjected
to histological analysis.
Micro-CT scanning
For morphological observation, the specimens were
scanned using a micro-CT (Hitachi-Aloka Medical, Tokyo,
Japan) after euthanasia. Sliced CT data were three-
dimensionally reconstructed (Real INTAGE, Kubota
Graphics Technology, Tokyo, Japan).
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Specimens were fixed in 4% paraformaldehyde, decalci-
fied with 0.5 M ethylenediaminetetraacetic acid (EDTA),
and embedded in paraffin wax. Sagittal sections (5 μm
thick) were stained with safranin O and Weigert’s iron
hematoxylin and then examined by light microscopy.
For immunohistochemistry, sections were pretreated
with 0.4 mg/mL proteinase K (DAKO, Carpinteria, CA,
USA) for 10 min at room temperature. Endogenous per-
oxidases were quenched using 3% hydrogen peroxide in
methanol for 20 min at room temperature. The sections
were then incubated with mouse polyclonal antibody
against type II collagen (F-57 anti-hCL (II), FUJI Chemical
Industries, Toyama, Japan) and rabbit polyclonal antibody
against type X collagen (ab58632, Abcam, Cambridge,
MA, USA) at room temperature for 1 h. The immu-
nostaining was performed using the VECTASTAIN ABC
reagent (Vector Laboratories, Burlingame, CA, USA) and
developed in 3,3’-diaminobenzidine and 0.02% H2O2 with
hematoxylin counterstaining.
Histological scoring
Histological findings were scored according to a scale
described by Wakitani et al. [9]. Sections were graded
according to 1) cell morphology (maximum 4 points), 2)
matrix staining (maximum 3 points), 3) surface regularity
(maximum 3 points), 4) thickness of cartilage (maximum
2 points), and 5) integration of donor material into adja-
cent host cartilage (maximum 2 points). Scoring was
performed blindly by two orthopedic surgeons who were
independent of this study, and the average of each score
was adopted.Figure 2 Scanning electron micrographs of HDMACs. SEMs showed th
some amount of collagen fibers. Original magnifications were (a) 430×, (b)Cell tracking
At first passage, cells were re-suspended at in DMEM
1.0 × 106 cells/mL and then were labeled with Qtracker
655 Cell Labeling Kit (Quantum Dot Corp., Hayward,
CA, USA).
The day after the cell labeling, the cells proceeded to
spheroid formation as described above. HDMACs gener-
ated using the labeled cells were implanted in rabbit
knees as described above, and the rabbits were 6 weeks
later for histological examination.Statistical analysis
For in vivo investigations, nonparametric comparisons
were performed using Student’s t test. P values less
than 0.05 were considered to represent statistical
significance.Results
Histology and scanning electron micrographs of HDMACs
Histological examination of HDMACs with safranin O
staining after 1 week of incubation revealed that the
nucleus of cells were stained without fragmentation or
chromatin condensation at the whole area of the section,
suggesting that the cells in the construct were viable
and did not undergo apoptosis (Figure 1d). The matrix
was not stained red, suggesting that the cells in the
HDMACs had not been differentiated into chondrocytes
before the implantation. The ultrastructural morphology
of the HDMACs was assessed by SEM. The micrographs
revealed that these constructs contained flattened cells
with some amount of collagen fibers (Figure 2).at these constructs contained flattened cells (arrows and frames) with
1,000×, and (c) 2,500×. Scale bar =10 μm. (N = 1).
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defect
To test our hypothesis that HDMACs would be able to
simultaneously regenerate cartilage and bone, two or
three rabbits were euthanized at 3, 6, and 12 weeks and
morphologically and histologically assessed (Figures 3a–i
and 4a–i). After 6 weeks of implantation, the surface of
the defect was covered with cartilaginous white tissue.
Micro-CT scanning also suggested that bone formations
were present at the peripheral areas and developed toward
the central area. Histological examination suggested that
cartilaginous differentiation, which was detected by safra-
nin O staining and immunostaining for type II collagens,
occurred at peripheral areas of the implanted HDMACs
and developed toward the central area. At 6 weeks, all the
implanted area showed positive staining for safranin O
and type II collagen. At 12 weeks, endochondral bone
formation progressed, and almost the whole area corre-
sponding to the subchondral bone was replaced by boneFigure 3 Early repair processes in osteochondral defects. Gross appear
implantation, the surface of the defect was covered with cartilaginous whit
12 weeks suggested that bone formations were present at the peripheral a
(k, l) micro-CT scanning of a control rabbit without any implantation at 12
filled with white tissues, the subchondral bone formation was incomplete
the borders of the defect. Representative subjects of two or three experimestructures. At the joint surface area of the implanted
tissue, hyaline cartilage was regenerated with a con-
stant thickness.
By contrast, in a control rabbit without any implant-
ation, the defect was filled with fibrous tissue. Although
a spontaneous repairing process was observed at the per-
ipheral area that showed slight staining for safranin O or
type II collagen, the cartilage formation and the subchon-
dral bone formation were incomplete at the central area
even at 12 weeks (Figures 3j–l and 4j–l).
Cell tracking
HDMACs were made with labeled MSCs and implanted
into the osteochondral defect. Labeled cells were detected
as chondrocytes in the cartilage and osteocytes in the sub-
chondral bone 6 weeks after implantation, suggesting that
the implanted MSCs had spontaneously differentiated into
chondrocytes or osteocytes in accordance with their im-
planted positions (Figure 5).ance at (a) 3 weeks, (d) 6 weeks, and (g) 12 weeks. After 6 weeks of
e tissue. Micro-CT scanning at (b, c) 3 weeks, (e, f) 6 weeks, and (h, i)
reas and developed toward the central area. (j) Gross appearance and
weeks. Although the gross appearance showed that the defect was
at the center of the defect at 12 weeks. Downwards arrows indicate
nts for each time course are shown.
Figure 4 Histological examination at early repair processes in osteochondral defects. Safranin O staining, immunostaining for type II
collagens, and IgG staining as controls at (a–c) 3 weeks, (d–f) 6 weeks, and (g–i) 12 weeks after the implantation. At 3 weeks, the implanted
tissue had not differentiated into hyaline cartilage yet. At 6 and 12 weeks, the joint surface area of the implanted tissue was stained with safranin
O and immunostained for type II collagen. Endochondral bone formation was observed at the peripheral area at 6 weeks and developed toward
the central area at 12 weeks. (j–l) A control rabbit without any implantation at 12 weeks. The defect was filled with fibrous tissue that did show a
constant staining for safranin O and immunostaining for type II collagen, especially at the surface and central areas. Scale bar = 1 mm. Downwards
arrows indicate the borders of the defect. Representative subjects of two or three experiments for each time course are shown.
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After obtaining the preliminary results regarding the
early regeneration process, we focused on morphological
and histological evaluation at 24 and 52 weeks (n = 3
each) (Figures 6a–j and 7a–h). CT scans revealed completeFigure 5 Cell tracking. HDMACs made with labeled MSCs were implanted
chondrocytes in the cartilage and osteocytes in the subchondral bone 6 w
spontaneously differentiated into chondrocytes or osteocytes in accordancregeneration of the subchondral bone. Histological exam-
ination revealed that hyaline cartilage, which was stained
for safranin O and immunostained for type II collagen, was
maintained at a consistent thickness identical to that of the
surrounding original cartilage at both 24 and 52 weeks.to the osteochondral defect. The labeled cells were detected as
eeks after implantation, suggesting that the implanted MSCs had
e with their implanted positions. Scale bar = 200 μm. (N = 1).
Figure 6 Morphological and histological examination at 24 and 52 weeks. Gross appearance, micro-CT scanning, and safranin O staining at
(a–e) 24 weeks and (f–j) 52 weeks. Micro-CT scans revealed complete regeneration of the subchondral bone. Histological examination revealed
that the regenerated cartilage was maintained with a consistent thickness identical to that of the surrounding original cartilage at both (d)
24 weeks and (i) 52 weeks. Scale bar = 1 mm. (e, j) Tidemarks, which separate hyaline cartilage from the calcified cartilage, were seen (arrows).
Scale bar = 100 μm. (k–o) A control rabbit without any implantation at 52 weeks. The defect was mainly filled with fibrous tissue that did not
exhibit formation of subchondral bone (m) or sufficient staining with safranin O (n). Although some area was stained with safranin O, tidemark
was not formed (o). Downwards arrows indicate the borders of the defect. Representative subjects of three experiments for each time course
are shown.
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tive staining in the implanted area during the regeneration
period. Tidemark, which separates hyaline cartilage from
the calcified cartilage layer, was seen in these two groups,
suggesting the integrality of the regenerated articular
structures. By contrast, a control rabbit without any
implantation showed that the defect was mainly filled with
fibrous tissue that did not exhibit the consistent staining
for safranin O or formation of the subchondral bone.Figure 7 Immunohistochemistry at 24 and 52 weeks. Safranin O stainin
for type X collagens (c, g), and IgG staining as controls (d, h) at 24 weeks
collagens was observed in the implanted area during the regeneration per
for each time course are shown.Although some area was stained with safranin O, tidemark
was not formed (Figure 6k–o).
The mean histological score was 10 ± 1.7 (standard
error (S.E.)) in the 24-week group and 9.7 ± 0.6 (S.E.)
in the 52-week group. There was no significant differ-
ence between the 24- and 52-week groups in either
parameter of the score, indicating that no deterioration
of the repaired tissue took place during this period
(Table 1).g (a, e), immunostaining for type II collagens (b, f), immunostaining
(a–d) and 52 weeks (e–h). No positive Immunostaining for type X
iod. Scale bar =200 μm. Representative subjects of three experiments







Cell morphology 2.7 (2–3) 2.7 (2–3) N.S.
Matrix staining (metachromasia) 1.7 (1–2) 1.7 (1–2) N.S.
Surface regularity 3 3 N.S.
Thickness of cartilage 1.3 (1–2) 1.7 (1–2) N.S.
Integration of donor to
adjacent host cartilage
1.3 (1–2) 0.7 (0–1) N.S.
Total score (score range 0–14) 10 (8–11) 9.7 (9–10) N.S.
N.S. not significant.
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In this study, we demonstrated successful regeneration
of articular cartilage and subchondral bone in an
osteochondral defect of rabbit knee joints using three-
dimensional HDMACs. The HDMACs were made
without using any differentiation agents, such as growth
factors, and were implanted to the osteochondral defect
while the cells in the construct were undifferentiated. The
implanted MSCs spontaneously differentiated into bone
or cartilage, depending on the environment in which they
were implanted, and maintained the original border
between bone and cartilage. Eventually, by the 52-week
follow-up, the simultaneous regeneration of bone and
cartilage had been completed. The unique features of our
method are as follows: 1) A three-dimensional MSC
construct with sufficient thickness for bone and cartilage
repair can be made without a scaffold. 2) The construct is
implanted without induction of differentiation. 3) Sim-
ultaneous regeneration of bone and cartilage occurs
spontaneously by reproducing the differentiation process
involved in bone and cartilage formation. A major
strength of our study is that we could confirm that the
regenerated bone and cartilage were maintained for up to
52 weeks.
However, one limitation of our study is that we did
not make an effort to increase the sample sizes for the
short-term results (e.g., within 12 weeks). After confirm-
ing in a few samples that MSCs spontaneously differenti-
ate into bone or cartilage in vivo, as we originally
hypothesized, we placed greater emphasis on investigat-
ing the long-term results. We chose this course because
a large number of previous studies using other methods
had succeeded over the short term, but it remained that
deterioration of the repaired cartilage would occur over
long-term observation. Some previous studies using a
scaffold reported frequent invasion of a bony structure
into the repaired cartilage, causing the cartilage to be-
come thinner than the surrounding normal articular
cartilage [9,17]. Furthermore, a scaffold has the potential
to influence surrounding microenvironments, which canaffect the regional specification of implanted MSCs
[10]. The presence of nonphysiological scaffolds could
interfere with the physiological distribution of signal
molecules, such as growth factors, that influence the
differentiation of cells toward bone and cartilage.
Following a report of the efficacy of ACI by Brittberg
et al. [4], chondrocytes have been widely used in the
field of articular cartilage regeneration. The form of the
grafts used for implantation varies from monolayer cul-
ture [4] to tissue-engineered three-dimensional cultures
in agarose [18] or atelocollagen gel [19]. A number of
clinical trials have been conducted, and some of them
reported successful outcomes in regard to patients’ symp-
toms or imaging endpoints [19,20]. However, it should be
noted that ACI was more effective in patients younger
than 45 years than in older patients [21]. In fact, the mean
age of clinical trials with satisfactory outcomes for rela-
tively long follow-up periods ranges from 26.4 to 33.1 years
old [19,22]. This result may be related to the shortening of
telomeres in many adult cells, including chondrocytes
[23]. Therefore, it may be necessary to use alternative
methods in middle-aged and elderly patients.
Bone and cartilage have the same origin, i.e., MSCs. In
a previous work, patient age made no difference in out-
comes of methods using MSCs [21]. Therefore, MSCs
represent an attractive alternative to adult chondrocytes
as a cell source for bone and cartilage regeneration.
However, it is challenging to artificially control differen-
tiation into the osteocyte or chondrocyte lineage after
implantation. The underlying molecular mechanism of
our method, in which a bone and articular cartilage
defect was repaired while maintaining the border be-
tween cartilage and subchondral bone, is currently un-
clear. However, cell tracking analysis revealed that both
cell types in the repaired tissues were derived dominantly
from the implanted MSCs within the construct rather
than the migrated cells from the surrounding tissues
(Figure 5). Our HDMACs may mimic the cellular inte-
gration of embryonic osteogenesis and chondrogenesis
that originates from mesenchymal condensation. The
HDMACs were implanted without pretreatment to induce
differentiation. The micrographs by SEM revealed that the
HDMACs contained flattened cells, not ovary-shaped
chondrocyte-like cells (Figure 2). Combined with the
fact that the HDMACs were not stained with safranin O
(Figure 1d), these cells are suggested to be undifferen-
tiated. On the other hand, we also confirmed that the con-
structs could undergo differentiation into chondrocytes
in vitro when cultured in chondrocyte induction medium
(data not shown). In vivo, the implanted MSCs spon-
taneously differentiate into articular cartilage and sub-
chondral bone; eventually, the normal structures of bone
and cartilage were completely formed (Figures 6 and 7).
In addition, type X collagen was not expressed in the
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lar cartilage, one of the major problems using MSC-based
constructs, did not occur during the regeneration period.
Our study is distinguished not only by the use of
undifferentiated MSCs but also by the use of a construct
generated by a scaffold-free method. Our HDMACs have
enough volume to fill a full-thickness cartilage defect.
Cell nutrition particularly in the middle of a big con-
struct can be a concern [24]. However, the nucleus was
stained with hematoxylin in the middle of the HDMACs
and there was no fragmentation or chromatin condensa-
tion (Figure 1d). This suggests that the cells in the con-
struct were viable. Previous studies developed various
scaffold-free methods using chondrocytes or MSCs; the
simplest reported method is injection of synovial MSCs
into a cartilage defect in vivo [16]. In that study, how-
ever, although the histological score was significantly
greater than the control, the depth of the defect was re-
stricted to 2 mm and the surface was concave. Another
method using a scaffold-free construct derived from syn-
ovial MSCs resulted in successful repair of a cartilage
defect [14], but again, the depth was limited to 2 mm. In
yet another study, scaffold-free chondrocyte sheets were
used successfully to repair of a partial-thickness cartilage
defect in vivo [13]. However, this method was insuffi-
cient for subchondral bone repair and tissue integration
in the context of a full-thickness cartilage defect [25]. In
efforts to obtain enough cell mass to fill a full-thickness
cartilage defect, pellet cultures of chondrocytes or MSCs
have been investigated. In one animal study, chondrocyte
pellet implantation into a 3-mm osteochondral defect was
attempted [15]. Although the thickness of the repaired
cartilage remained relatively constant, overgrowth of the
surface was observed, and subchondral bone regeneration
was extremely limited.Conclusions
Our novel technique, using a three-dimensional scaffold-
free autologous construct derived from BM-MSCs, suc-
cessfully achieved the simultaneous regeneration of bone
and cartilage for up to 1 year in vivo. This method has
potential for clinical use as a safe and effective method
for repairing bone and cartilage defects.Competing interests
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